ARDX
Ardelyx, Inc.
Price Chart
Latest Quote
$5.79
+0.18 (+3.21%)
Current Price
| Previous Close | $5.61 |
| Open | $5.60 |
| Day High | $5.90 |
| Day Low | $5.54 |
| Volume | 3,631,593 |
Stock Information
| Shares Outstanding | 247.03M |
| Total Debt | $234.13M |
| Cash Equivalents | $238.07M |
| Revenue | $427.68M |
| Net Income | $-58.06M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.41B |
| EPS (TTM) | $-0.24 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.40B |
| Sales | $427.68M |
| Income | $-58.06M |
| Book/sh | $0.60 |
| Cash/sh | $0.96 |
| Employees | 489 |
Financial Ratios
| Quick Ratio | 2.93 |
| Current Ratio | 3.48 |
| Debt/Eq | 157.53 |
Returns & Margins
| ROA | -5.11% |
| ROE | -39.46% |
| Gross Margin | 74.56% |
| Operating Margin | -34.71% |
| Profit Margin | -13.58% |
Ownership
| Insider Ownership | 3.19% |
| Institutional Ownership | 70.66% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 11.05 |
| P/S | 3.29 |
| P/B | 9.45 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $16.33 |
Technical Indicators
| SMA20 | $5.89 |
| SMA50 | $6.17 |
| SMA200 | $6.13 |
| RSI | 37.50 |
| ATR | 0.2554 |
| Shares Float | 219.85M |
| Short Float | 10.25% |
| Short Ratio | 5.83 |
| Volatility | 0.58 |
| Rel Volume | 0.90 |
Performance History
| Week | +2.34% |
| Month | -10.82% |
| Quarter | -1.56% |
| 6 Months | -3.89% |
| YTD | -7.48% |
| Year | +53.78% |
| 3 Years | +51.33% |
| 5 Years | -18.83% |
| 10 Years | -34.52% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-12 | $5.69 | 2,628,400 |
| 2026-06-11 | $5.79 | 3,651,900 |
| 2026-06-10 | $5.61 | 2,939,900 |
| 2026-06-09 | $5.60 | 2,978,000 |
| 2026-06-08 | $5.54 | 1,817,400 |
| 2026-06-05 | $5.56 | 4,589,700 |
| 2026-06-04 | $5.40 | 2,572,500 |
| 2026-06-03 | $5.42 | 3,821,300 |
| 2026-06-02 | $5.52 | 4,149,200 |
| 2026-06-01 | $5.73 | 2,628,600 |
| 2026-05-29 | $6.04 | 2,801,600 |
| 2026-05-28 | $6.25 | 1,979,400 |
| 2026-05-27 | $6.17 | 2,335,800 |
| 2026-05-26 | $6.25 | 2,605,400 |
| 2026-05-22 | $6.11 | 2,318,000 |
| 2026-05-21 | $6.35 | 2,927,400 |
| 2026-05-20 | $6.27 | 2,793,600 |
| 2026-05-19 | $6.09 | 2,357,700 |
| 2026-05-18 | $6.11 | 3,132,800 |
| 2026-05-15 | $6.23 | 3,244,100 |
| 2026-05-14 | $6.46 | 2,075,800 |
| 2026-05-13 | $6.38 | 7,236,300 |
About Ardelyx, Inc.
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
đ° Latest News
Ardelyx (ARDX) Stock Valuation Check After Recent Share Price Volatility
Simply Wall St. âĸ 2026-06-12T18:11:10Z
Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach
MarketBeat âĸ 2026-06-04T12:04:32Z
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability âRight Around The Cornerâ
Stocktwits âĸ 2026-06-03T23:52:44Z
Should You Buy Ardelyx (ARDX)?
Insider Monkey âĸ 2026-05-30T15:18:01Z
Ardelyx (ARDX) Is Up 10.3% After Long-Term XPHOZAH Safety Data In Dialysis Patients - What's Changed
Simply Wall St. âĸ 2026-05-09T15:11:54Z
Assessing Ardelyx (ARDX) Valuation After Q1 2026 Results And Reaffirmed Revenue Guidance
Simply Wall St. âĸ 2026-05-07T15:25:57Z
Analyst Estimates: Here's What Brokers Think Of Ardelyx, Inc. (NASDAQ:ARDX) After Its First-Quarter Report
Simply Wall St. âĸ 2026-05-02T13:16:28Z
Ardelyx Inc (ARDX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
GuruFocus.com âĸ 2026-05-01T07:19:43ZArdelyx, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-01T00:15:30Z
Ardelyx (ARDX) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-04-30T23:32:36Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $39,537,000 | $50,556,000 | $17,795,000 | $4,117,000 |
| Cost Of Revenue | $39,537,000 | $50,556,000 | $17,795,000 | $4,117,000 |
| Total Revenue | $407,320,000 | $333,615,000 | $124,456,000 | $52,158,000 |
| Operating Revenue | $407,320,000 | $333,615,000 | $124,456,000 | $52,158,000 |
| Expenses | ||||
| Interest Expense | $28,398,000 | $20,094,000 | $8,874,000 | $5,073,000 |
| Total Expenses | $448,297,000 | $361,565,000 | $187,732,000 | $115,917,000 |
| Other Income Expense | $8,745,000 | $9,174,000 | $6,630,000 | $1,633,000 |
| Other Non Operating Income Expenses | $8,745,000 | $9,174,000 | $6,630,000 | $1,633,000 |
| Net Non Operating Interest Income Expense | $-28,398,000 | $-20,094,000 | $-8,874,000 | $-5,073,000 |
| Interest Expense Non Operating | $28,398,000 | $20,094,000 | $8,874,000 | $5,073,000 |
| Operating Expense | $408,760,000 | $311,009,000 | $169,937,000 | $111,800,000 |
| General And Administrative Expense | - | - | - | $76,599,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Net Interest Income | $-28,398,000 | $-20,094,000 | $-8,874,000 | $-5,073,000 |
| Normalized Income | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Net Income From Continuing And Discontinued Operation | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Total Operating Income As Reported | $-40,977,000 | $-27,950,000 | $-63,276,000 | $-63,759,000 |
| Net Income Common Stockholders | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Net Income | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Net Income Including Noncontrolling Interests | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Net Income Continuous Operations | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Pretax Income | $-60,630,000 | $-38,870,000 | $-65,520,000 | $-67,199,000 |
| Operating Income | $-40,977,000 | $-27,950,000 | $-63,276,000 | $-63,759,000 |
| Gross Profit | $367,783,000 | $283,059,000 | $106,661,000 | $48,041,000 |
| Per Share | ||||
| Diluted EPS | $-0.26 | $-0.17 | $-0.30 | $-0.42 |
| Basic EPS | $-0.26 | $-0.17 | $-0.30 | $-0.42 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-29,173,000 | $-16,713,000 | $-55,354,000 | $-60,982,000 |
| Reconciled Depreciation | $3,059,000 | $2,063,000 | $1,292,000 | $1,144,000 |
| EBITDA (Bullshit earnings) | $-29,173,000 | $-16,713,000 | $-55,354,000 | $-60,982,000 |
| EBIT | $-32,232,000 | $-18,776,000 | $-56,646,000 | $-62,126,000 |
| Diluted Average Shares | $241,033,750 | $235,232,927 | $219,331,253 | $158,690,083 |
| Basic Average Shares | $241,033,750 | $235,232,927 | $219,331,253 | $158,690,083 |
| Diluted NI Availto Com Stockholders | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Tax Provision | $969,000 | $266,000 | $547,000 | $8,000 |
| Research And Development | $71,527,000 | $52,317,000 | $35,536,000 | $35,201,000 |
| Selling General And Administration | $337,233,000 | $258,692,000 | $134,401,000 | $76,599,000 |
| Other Gand A | - | - | - | $76,599,000 |
Fetched: 2026-06-12
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $166,949,000 | $173,289,000 | $166,816,000 | $98,329,000 |
| Total Assets | $501,604,000 | $435,754,000 | $297,579,000 | $190,066,000 |
| Total Non Current Assets | $119,287,000 | $79,302,000 | $51,468,000 | $36,463,000 |
| Other Non Current Assets | $112,308,000 | $75,427,000 | $40,635,000 | $25,945,000 |
| Current Assets | $382,317,000 | $356,452,000 | $246,111,000 | $153,603,000 |
| Other Current Assets | $13,566,000 | $11,096,000 | $8,408,000 | $5,112,000 |
| Prepaid Assets | $14,479,000 | $16,378,000 | $18,925,000 | $13,567,000 |
| Inventory | $17,735,000 | $21,173,000 | $12,448,000 | $3,282,000 |
| Receivables | $71,848,000 | $57,705,000 | $22,031,000 | $7,733,000 |
| Accounts Receivable | $71,848,000 | $57,705,000 | $22,031,000 | $7,733,000 |
| Cash Cash Equivalents And Short Term Investments | $264,689,000 | $250,100,000 | $184,299,000 | $123,909,000 |
| Cash And Cash Equivalents | $67,999,000 | $64,932,000 | $21,470,000 | $96,140,000 |
| Cash Equivalents | $49,430,000 | $48,650,000 | $18,641,000 | $84,313,000 |
| Cash Financial | $18,569,000 | $16,282,000 | $2,829,000 | $11,827,000 |
| Non Current Prepaid Assets | - | $0 | $4,235,000 | $0 |
| Debt | ||||
| Net Debt | $134,835,000 | $85,921,000 | $28,352,000 | - |
| Total Debt | $207,954,000 | $153,438,000 | $55,982,000 | $36,460,000 |
| Long Term Debt And Capital Lease Obligation | $206,475,000 | $151,876,000 | $51,547,000 | $5,855,000 |
| Long Term Debt | $202,834,000 | $150,853,000 | $49,822,000 | - |
| Current Debt And Capital Lease Obligation | $1,479,000 | $1,562,000 | $4,435,000 | $30,605,000 |
| Current Debt | - | - | - | $26,711,000 |
| Other Current Borrowings | - | - | - | $26,711,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $334,655,000 | $262,465,000 | $130,763,000 | $91,737,000 |
| Total Non Current Liabilities Net Minority Interest | $246,050,000 | $184,635,000 | $80,370,000 | $26,134,000 |
| Non Current Deferred Liabilities | $39,575,000 | $32,759,000 | $28,823,000 | $20,279,000 |
| Current Liabilities | $88,605,000 | $77,830,000 | $50,393,000 | $65,603,000 |
| Other Current Liabilities | $7,348,000 | $6,538,000 | $4,880,000 | $2,541,000 |
| Current Deferred Liabilities | $1,206,000 | $10,686,000 | $7,182,000 | $4,211,000 |
| Payables And Accrued Expenses | $59,464,000 | $44,104,000 | $21,299,000 | $20,698,000 |
| Payables | $19,235,000 | $16,000,000 | $11,138,000 | $10,859,000 |
| Accounts Payable | $19,235,000 | $16,000,000 | $11,138,000 | $10,859,000 |
| Interest Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $166,949,000 | $173,289,000 | $166,816,000 | $98,329,000 |
| Total Equity Gross Minority Interest | $166,949,000 | $173,289,000 | $166,816,000 | $98,329,000 |
| Stockholders Equity | $166,949,000 | $173,289,000 | $166,816,000 | $98,329,000 |
| Gains Losses Not Affecting Retained Earnings | $198,000 | $57,000 | $224,000 | $-54,000 |
| Other Equity Adjustments | $198,000 | $57,000 | $224,000 | $-54,000 |
| Retained Earnings | $-946,939,000 | $-885,340,000 | $-846,204,000 | $-780,137,000 |
| Other | ||||
| Ordinary Shares Number | $244,351,501 | $238,015,825 | $232,453,190 | $198,575,016 |
| Share Issued | $244,351,501 | $238,015,825 | $232,453,190 | $198,575,016 |
| Tangible Book Value | $166,949,000 | $173,289,000 | $166,816,000 | $98,329,000 |
| Invested Capital | $369,783,000 | $324,142,000 | $216,638,000 | $125,040,000 |
| Working Capital | $293,712,000 | $278,622,000 | $195,718,000 | $88,000,000 |
| Capital Lease Obligations | $5,120,000 | $2,585,000 | $6,160,000 | $9,749,000 |
| Total Capitalization | $369,783,000 | $324,142,000 | $216,638,000 | $98,329,000 |
| Additional Paid In Capital | $1,113,666,000 | $1,058,548,000 | $1,012,773,000 | $878,500,000 |
| Capital Stock | $24,000 | $24,000 | $23,000 | $20,000 |
| Common Stock | $24,000 | $24,000 | $23,000 | $20,000 |
| Non Current Deferred Revenue | $13,699,000 | $7,232,000 | $8,644,000 | $9,025,000 |
| Long Term Capital Lease Obligation | $3,641,000 | $1,023,000 | $1,725,000 | $5,855,000 |
| Current Deferred Revenue | $1,206,000 | $10,686,000 | $7,182,000 | $4,211,000 |
| Current Capital Lease Obligation | $1,479,000 | $1,562,000 | $4,435,000 | $3,894,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $19,108,000 | $14,940,000 | $12,597,000 | $7,548,000 |
| Current Accrued Expenses | $40,229,000 | $28,104,000 | $10,161,000 | $9,839,000 |
| Net PPE | $6,979,000 | $3,875,000 | $6,598,000 | $10,518,000 |
| Accumulated Depreciation | $-2,650,000 | $-10,618,000 | $-10,201,000 | $-9,657,000 |
| Gross PPE | $9,629,000 | $14,493,000 | $16,799,000 | $20,175,000 |
| Leases | $2,148,000 | $9,144,000 | $8,731,000 | $8,745,000 |
| Other Properties | $4,795,000 | $2,426,000 | $5,635,000 | $9,341,000 |
| Machinery Furniture Equipment | $2,686,000 | $2,923,000 | $2,433,000 | $2,089,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $196,690,000 | $185,168,000 | $162,829,000 | $27,769,000 |
| Treasury Shares Number | - | - | $0 | - |
| Preferred Stock | - | - | $0 | $0 |
| Investments And Advances | - | - | - | - |
Fetched: 2026-06-12
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-43,975,000 | $-45,820,000 | $-90,061,000 | $-70,099,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-42,483,000 | $-44,809,000 | $-89,717,000 | $-70,044,000 |
| Cash Flow From Continuing Operating Activities | $-42,483,000 | $-44,809,000 | $-89,717,000 | $-70,044,000 |
| Operating Gains Losses | - | - | - | $-1,260,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,492,000 | $-1,011,000 | $-344,000 | $-55,000 |
| Investing Cash Flow | $-8,959,000 | $-18,318,000 | $-131,248,000 | $18,415,000 |
| Cash Flow From Continuing Investing Activities | $-8,959,000 | $-18,318,000 | $-131,248,000 | $18,415,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $0 | $119,236,000 | $71,625,000 |
| Financing Cash Flow | $54,509,000 | $106,589,000 | $146,295,000 | $75,341,000 |
| Cash Flow From Continuing Financing Activities | $54,509,000 | $106,589,000 | $146,295,000 | $75,341,000 |
| Net Common Stock Issuance | $0 | $0 | $119,236,000 | $71,625,000 |
| Common Stock Issuance | $0 | $0 | $119,236,000 | $71,625,000 |
| Net Other Financing Charges | - | $-1,000,000 | $3,500,000 | $9,581,000 |
| Other | ||||
| Issuance Of Debt | $48,668,000 | $99,451,000 | $22,386,000 | $26,971,000 |
| Interest Paid Supplemental Data | $15,717,000 | $11,408,000 | $4,240,000 | $2,901,000 |
| Income Tax Paid Supplemental Data | $485,000 | $266,000 | $51,000 | $6,000 |
| End Cash Position | $67,999,000 | $64,932,000 | $21,470,000 | $96,140,000 |
| Beginning Cash Position | $64,932,000 | $21,470,000 | $96,140,000 | $72,428,000 |
| Changes In Cash | $3,067,000 | $43,462,000 | $-74,670,000 | $23,712,000 |
| Proceeds From Stock Option Exercised | $5,841,000 | $8,138,000 | $1,173,000 | $202,000 |
| Net Issuance Payments Of Debt | $48,668,000 | $99,451,000 | $22,386,000 | $-6,067,000 |
| Net Long Term Debt Issuance | $48,668,000 | $99,451,000 | $22,386,000 | $-6,067,000 |
| Long Term Debt Issuance | $48,668,000 | $99,451,000 | $22,386,000 | $26,971,000 |
| Net Investment Purchase And Sale | $-7,467,000 | $-17,307,000 | $-130,904,000 | $16,672,000 |
| Sale Of Investment | $211,456,000 | $177,854,000 | $84,321,000 | $67,000,000 |
| Purchase Of Investment | $-218,923,000 | $-195,161,000 | $-215,225,000 | $-50,328,000 |
| Net PPE Purchase And Sale | $-1,492,000 | $-1,011,000 | $-344,000 | $1,743,000 |
| Purchase Of PPE | $-1,492,000 | $-1,011,000 | $-344,000 | $-55,000 |
| Change In Working Capital | $-31,352,000 | $-49,169,000 | $-43,386,000 | $-19,575,000 |
| Change In Other Working Capital | $-3,013,000 | $2,092,000 | $2,590,000 | $8,509,000 |
| Change In Other Current Liabilities | $-1,827,000 | $-4,588,000 | $-3,928,000 | $-3,491,000 |
| Change In Payables And Accrued Expense | $21,948,000 | $28,459,000 | $9,019,000 | $12,846,000 |
| Change In Accrued Expense | $18,713,000 | $23,597,000 | $8,740,000 | $6,264,000 |
| Change In Payable | $3,235,000 | $4,862,000 | $279,000 | $6,582,000 |
| Change In Account Payable | $3,235,000 | $4,862,000 | $279,000 | $6,582,000 |
| Change In Prepaid Assets | $-2,394,000 | $2,239,000 | $-15,628,000 | $-1,862,000 |
| Change In Inventory | $-31,923,000 | $-41,697,000 | $-21,141,000 | $-28,346,000 |
| Change In Receivables | $-14,143,000 | $-35,674,000 | $-14,298,000 | $-7,231,000 |
| Changes In Account Receivables | $-14,143,000 | $-35,674,000 | $-14,298,000 | $-7,231,000 |
| Other Non Cash Items | $-1,553,000 | $4,052,000 | $4,914,000 | $6,104,000 |
| Stock Based Compensation | $48,962,000 | $37,381,000 | $13,530,000 | $10,750,000 |
| Depreciation Amortization Depletion | $3,059,000 | $2,063,000 | $1,292,000 | $1,144,000 |
| Depreciation And Amortization | $3,059,000 | $2,063,000 | $1,292,000 | $1,144,000 |
| Net Income From Continuing Operations | $-61,599,000 | $-39,136,000 | $-66,067,000 | $-67,207,000 |
| Repayment Of Debt | - | $0 | $0 | $-33,038,000 |
| Long Term Debt Payments | - | $0 | $0 | $-33,038,000 |
| Sale Of PPE | - | $0 | $0 | $1,798,000 |
| Gain Loss On Sale Of PPE | - | $0 | $0 | $-1,260,000 |
| Gain Loss On Investment Securities | - | - | - | $583,000 |
| Amortization Of Securities | - | - | - | - |
| Depreciation | - | - | - | - |
Fetched: 2026-06-12